Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Johnson and Johnson
Boehringer Ingelheim
Covington
Cantor Fitzgerald
Harvard Business School
Daiichi Sankyo
Argus Health

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020938

« Back to Dashboard

NDA 020938 describes MOBIC, which is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from three suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the MOBIC profile page.

The generic ingredient in MOBIC is meloxicam. There are twenty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 020938
Tradename:MOBIC
Applicant:Boehringer Ingelheim
Ingredient:meloxicam
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020938
Suppliers and Packaging for NDA: 020938
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOBIC meloxicam TABLET;ORAL 020938 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0029 N 0597-0029-94
MOBIC meloxicam TABLET;ORAL 020938 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0029 N 0597-0029-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Apr 13, 2000TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Aug 23, 2000TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Fuji
Queensland Health
Teva
UBS
Boehringer Ingelheim
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.